Cancer Research Annual Meeting 2010  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 3383-3386, July 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, H. M.
Right arrow Articles by Raffeld, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, H. M.
Right arrow Articles by Raffeld, M.

Mutations in the Coding Region of c-MYC in AIDS-associated and Other Aggressive Lymphomas

Helen M. Clark, Takahiro Yano, Takemi Otsuki, Elaine S. Jaffe, Darryl Shibata and Mark Raffeld1

Hematopathology Section, Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland [H. M. C., T. Y., T. O., E. S. J., M. R.], and Department of Pathology, Los Angeles County-University of Southern California Medical Center, Los Angeles, California [D. S.]

Our previous studies of the translocated MYC gene in Burkitt's lymphoma showed the existence of clustered somatic mutations located in the transcriptional activation domain. We now report that aggressive lymphomas arising in the acquired immunodeficiency syndrome (AIDS) contain similar mutations and that the presence of mutations is correlated with the rearrangement of the oncogene. Mutations were also found in other de novo non-AIDS, non-Burkitt's aggressive lymphomas with MYC rearrangements. An unusual asparagine to serine mutation at codon 11 was identified in several transformed follicular lymphomas without MYC rearrangement but not in normal tissues from patients with this mutation. These findings indicate that AIDS-associated and other de novo aggressive lymphomas with the MYC gene rearrangement are subject to the same mutation and selection process that affects Burkitt's lymphomas.

1 To whom requests for reprints should be addressed, at Laboratory of Pathology, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD 20892.

Received 4/ 4/94. Accepted 5/23/94.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
R. S.Y. Cheung, J. T. Brooling, M. M. Johnson, K. J. Riehle, J. S. Campbell, and N. Fausto
Interactions between MYC and transforming growth factor alpha alter the growth and tumorigenicity of liver progenitor cells
Carcinogenesis, December 1, 2007; 28(12): 2624 - 2631.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. A. Blum, G. Lozanski, and J. C. Byrd
Adult Burkitt leukemia and lymphoma
Blood, November 15, 2004; 104(10): 3009 - 3020.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Gregory, Y. Qi, and S. R. Hann
Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization
J. Biol. Chem., December 19, 2003; 278(51): 51606 - 51612.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
D. SIWARSKI, J. KIM, L. DIAW, and K. HUPPI
Identification of a transcriptionally compromised allele of c-MYC in a North American family
J. Med. Genet., January 1, 2001; 38(1): 47 - 49.
[Full Text]


Home page
Genes Dev.Home page
R. Sears, F. Nuckolls, E. Haura, Y. Taya, K. Tamai, and J. R. Nevins
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Genes & Dev., October 1, 2000; 14(19): 2501 - 2514.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
D. W. Chang, G. F. Claassen, S. R. Hann, and M. D. Cole
The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic versus Proliferative Signals
Mol. Cell. Biol., June 15, 2000; 20(12): 4309 - 4319.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
M. A. Gregory and S. R. Hann
c-Myc Proteolysis by the Ubiquitin-Proteasome Pathway: Stabilization of c-Myc in Burkitt's Lymphoma Cells
Mol. Cell. Biol., April 1, 2000; 20(7): 2423 - 2435.
[Abstract] [Full Text]


Home page
BloodHome page
F. Bahram, N. von der Lehr, C. Cetinkaya, and L.-G. Larsson
c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover
Blood, March 15, 2000; 95(6): 2104 - 2110.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. V. Dang
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Mol. Cell. Biol., January 1, 1999; 19(1): 1 - 11.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Smith-Sørensen, E. M. Hijmans, R. L. Beijersbergen, and R. Bernards
Functional Analysis of Burkitt's Lymphoma Mutant c-Myc Proteins
J. Biol. Chem., March 8, 1996; 271(10): 5513 - 5518.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-Y. Chou, G. W. Hart, and C. V. Dang
c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas
J. Biol. Chem., August 11, 1995; 270(32): 18961 - 18965.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.